APA (7th ed.) Citation

Fathy Elhabal, S., El-Nabarawi, M. A., Abdelaal, N., Elrefai, M. F. M., Ghaffar, S. A., Khalifa, M. M., . . . Khasawneh, M. A. (2023). Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: Formulation optimization, characterization, in-vitro, in silico, and in-vivo study. Drug Delivery, 30(1), 1. https://doi.org/10.1080/10717544.2023.2241665

Chicago Style (17th ed.) Citation

Fathy Elhabal, Sammar, et al. "Development of Canagliflozin Nanocrystals Sublingual Tablets in the Presence of Sodium Caprate Permeability Enhancer: Formulation Optimization, Characterization, In-vitro, in Silico, and In-vivo Study." Drug Delivery 30, no. 1 (2023): 1. https://doi.org/10.1080/10717544.2023.2241665.

MLA (9th ed.) Citation

Fathy Elhabal, Sammar, et al. "Development of Canagliflozin Nanocrystals Sublingual Tablets in the Presence of Sodium Caprate Permeability Enhancer: Formulation Optimization, Characterization, In-vitro, in Silico, and In-vivo Study." Drug Delivery, vol. 30, no. 1, 2023, p. 1, https://doi.org/10.1080/10717544.2023.2241665.